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GENETICALLY MODIFIED FOODS IN THE
INTERNATIONAL ARENA:
TRADE CONFLICTS, LABELING CONTROVERSY, AND
THE IMPORTANCE
OF INFORMED CONSUMER CHOICE
Ilona M. Demenina*
I. INTRODUCTION
Do we really know what is in the food we eat? Most of us do
not know that the majority of foods found in grocery stores in the
United States contain Genetically Modified (GM) ingredients.1
Recent studies show that “[a]bout two-thirds of consumers do not
know supermarkets already offer GE2 food, and according to
surveys in 2001 and 2003 by the Pew Initiative on Food and
Biotechnology—an independent biotechnology group—only one in
five people thinks he or she has eaten a genetically modified
product.”3 Many U.S. consumers who are aware of GM foods are
concerned with the possible impacts on human health and the
environment.4
The concerns are not unique to U.S. consumers—the public
worldwide shares them.5 A recent British survey shows that the
public’s concern about GM foods is rapidly increasing.6 Most

* J.D., St. Thomas University (2006); Editor-in-Chief, St. Thomas Law Review;
B.A. Political Science, University of Alaska-Anchorage (2002).
1
Elizabeth Suh, GE Foods Still Lacking Consumer Awareness, WASH. TIMES,
Sept. 2, 2004, http://washingtontimes.com/upi-breaking/20040819-023903-2211r.htm.
2
The terms GE (Genetically Engineered) and GM (Genetically Modified) will
be used interchangeably throughout the article.
3
Suh, supra note 1.
4
Id.
5
See Kathleen Hart, An Introduction to Genetically Modified Foods, 10 RICH.
J.L. & TECH. 6 (2004) (In April of 2004, about one-fifth of the Austrian adults urged
the government to ban GM foods. “Fifteen grocery store chains in the United
Kingdom, France, Denmark, Sweden, Germany, and Switzerland…[pled] with
growers…and shippers to separate genetically modified corn from regular corn and
genetically modified soybeans from regular soybeans.”).
6
Health Fears Put Future of GM Foods in Doubt, THE EXPRESS, Sept. 2, 2004,
at 24 (discussing a recent survey for consumer magazine Which?, finding that “[f]iftyeight per cent [of consumers] are so concerned they try to avoid GM ingredients
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consumer uneasiness probably arises from the average consumer’s
lack of scientific knowledge about the sophisticated process of
genetic engineering. In addition, people know little of the long-term
health and environmental effects of GM foods due to the fact that
they entered the market little over a decade ago. As a result, the
controversy surrounding GM foods has been a hot topic in the
international arena for the past several years.
Genetically modified foods first entered the market in 1992.
Since then, the agricultural industry has experienced a scientific
breakthrough, resulting in advancements in both the quality and
quantity of food supplies worldwide.7 GM foods are “resistant to
pests and diseases…could grow in various environmental
conditions,…[and are] capable of maintaining improved flavor,
texture, shelf life, and protein content.”8 As a result of the benefits
derived from genetic modification, GM products are more
marketable and result in increased profits for the companies
involved in their production and distribution. The increased
marketability of GM foods has caused many multinational
corporations to vigorously sponsor GE research and lobby the
government for wider acceptance of GM foods.9 As with any profitdriven research, many ethical, environmental, legal, and health
concerns are often overlooked.
There have been zealous campaigns around the world both in
support and in opposition of GM foods.10 The issues of regulation
and labeling have caused friction between the United States and the
European Union (E.U.), which are engaged in a wide-ranging trade

altogether,” and that “[s]hoppers also have no confidence in food labelling [sic], with
sixty-one per cent convinced they are eating GM food without knowing it”).
7
See Chineme OK Anyadiegwu, Health Risks of Genetically Modified Food: A
Need for Unbiased Research into the Potential Health Risks of Genetically Engineered
Crop Products, 13 SAN JOAQUIN AGRIC. L. REV. 203, 203–04 (2003); See also Julian
Wong, Are Biotech Crops and Conventional Crops Like Products? An Analysis Under
GATT, 2003 DUKE L. & TECH. REV. 27, ¶ 3 (2003) (“A study by the U.S. Department
of Agriculture showed that the total pesticide use was reduced by 6.2 percent in 1997
as a result of the use of biotechnology.” Biotechnology also results in higher crop
yields, which means that land can be used for agricultural purposes for longer periods
of time, thus minimizing harm to the environment.).
8
Anyadiegwu, supra note 7, at 204.
9
See Kim JoDene Donat, Engineering Akerlof Lemons: Information Asymmetry,
Externalities, and Market Intervention in the Genetically Modified Food Market, 12
MINN. J. GLOBAL TRADE 417, 423 (2003).
10
See Michele M. Compton, Applying World Trade Organization Rules to the
Labeling of Genetically Modified Foods, 15 PACE INT’L L. REV. 359, 360 (2003).

312

S PRING 2006

Genetically Modified Foods

relationship with each other.11 This paper will compare the E.U. and
U.S. approach to regulating GM products while arguing that the
United States should adopt a labeling standard similar to that of the
E.U. and require more consumer education and input so that
consumers can make better informed decisions about the foods they
purchase. Part II of this article will discuss the existing
controversies between the United States and the European Union
with respect to the regulation and labeling of GM foods. Next, it
will make a comparison between the “permissive strategy”12
adopted by the United States and the new “precautionary
approach”13 followed by the E.U. Furthermore, Part II will
highlight the U.S. and E.U. laws concerning GM foods and policy
changes in view of the World Trade Organization’s (WTO) rules.
Part III will discuss the social and political settings that affect
the laws dealing with GM foods in different countries. Since,
admittedly, different political and economic priorities result in
different approaches to GM food regulation, this article will include
an examination of the reasons for such differing attitudes towards
biotechnology in the United States and the E.U. Furthermore, this
article will examine the role of corporate lobbyists and consumer
advocacy groups in pressuring U.S. and E.U. authorities to regulate
or de-regulate the GE industry.
Part IV will address the need for more public discussion arising
from the fact that consumers are largely left in the dark and
excluded from the decision-making process. Part IV will also assert
that the lack of public involvement has resulted in decreased
consumer confidence and that the public needs to receive more
information and more choices in order to rebuild consumer trust.14
In conclusion, this comment will call for the mandatory labeling of
GM foods sold in the United States, despite scientific findings
indicating an absence of health risks.

11

See Terence P. Stewart & David S. Johanson, Policy in Flux: The European
Union’s Laws on Agricultural Biotechnology and Their Effects on International
Trade, 4 DRAKE J. AGRIC. L. 243, 246 (1999); see also Jeffrey Sparshott, U.S., EU Sue
Each Other over Subsidies; Boeing, Airbus at Center of Market Friction, WASH.
TIMES, Oct. 7, 2004, at C08 (stating that the United States and the European Union
have the biggest trade partnership in the world, dealing goods and services worth over
US$400 billion per year).
12
Donat, supra note 9, at 427.
13
Id.
14
See Suh, supra note 1.
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Safety is not the only consideration for consumers—ethics,
morals, religion, personal beliefs, and individual preferences often
play an important role for people in deciding what goes into their
body. Safe or not, consumers should be able to make an informed
decision, and adopting labeling rules will serve that purpose.
II. REGULATIONS OF GENETICALLY MODIFIED ORGANISMS IN THE
UNITED STATES AND THE EUROPEAN UNION: RECENT HISTORY
AND THE ROLE OF THE WORLD TRADE ORGANIZATION
While the regulation of genetically modified organisms (GMO)
in the United States is tightening in response to U.S. consumer
concerns, E.U. policies are slowly relaxing, thus giving rise to
European consumer resistance. Historically, the U.S. government
has been very unhappy with the E.U.’s cautious approach and has
argued that the six-year moratorium on the importation of GM
foods (which was lifted in April 2004) cost U.S. farmers nearly
$300 million each year.15 In contrast, European lobbyists strongly
favor a ban on the importation and production of GM foods and
fear that the mixing of modified and conventional crops would limit
the ability of consumers to avoid GM foods.16
A. Regulatory Process in the United States
The regulatory scheme in the United States for approving
GMOs is well established and the process of introducing GM foods
into the market is fairly routine, although U.S. consumers have
challenged the entry of GM foods into U.S. markets.17 In the United
States there is no single government agency designated to deal with
matters of biotechnology. Instead, three different agencies regulate
GMOs: the United States Department of Agriculture (USDA), the

15
Paul Meller, Europe Rejects Looser Labels for Genetically Altered Food, N.Y.
TIMES, Sept. 9, 2004, at W7, available at http://www.agobservatory.org/headlines.
cfm?RefID=37075.
16
See EU Approves GMO Seed for Planting Across Bloc, IRISH TIMES, Sept. 9,
2004, at 12, available at http://www.planetark.com/dailynewsstory.cfm/newsid/27022/
story.htm [hereinafter EU Approves GMO Seed].
17
See Stewart & Johanson, supra note 11, at 246.
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Environmental Protection Agency (EPA), and the Food and Drug
Administration (FDA).18
The primary role of the USDA with regard to biotechnology is
the approval of testing, through the Animal and Plant Health
Inspection Service (APHIS), in order to ensure the safety of new
GMO varieties.19 APHIS issues an environmental impact statement
and then conducts field trials to determine whether the GM
products have any adverse effects.20 If no adverse effects are found,
GM products gain a “nonregulated status,” meaning that they can
be freely placed on the market and treated in the same way as nonGMO foods.21
The EPA conducts reviews of bio-engineered pesticides in
order to protect public health and the environment.22 The same laws
apply to GM food regulation as to existing similar non-GMO
products.23 The regulation is done under the Toxic Substances
Control Act (TSCA)24 and the Federal Insecticide, Fungicide, and
Rodenticide Act (FIFRA).25 The purpose of TSCA and FIFRA is to
create a comprehensive national system to protect human health
and the environment from chemical substances including GMOs
that contain pesticide chemicals.26
The FDA ensures the safety of GM foods for consumption.27
The FDA does not require safety reviews of GM foods before they
enter the market because it considers them to be “substantially
equivalent to conventional food.”28 Thus, as long as the end product

18

Heather N. Ellison, Genetically Modified Organisms: Does the Current
Regulatory System Compromise Consumer Health?, 10 PENN ST. ENVTL. L. REV. 345,
349 (2002).
19
Donat, supra note 9, at 428. The USDA’s authority to regulate GM foods
stemmed from the Plant Pest Act and the Plant Quarantine Act. Both acts were
repealed in 2000. However, the USDA continues to have authority to limit or prohibit
the movement of GM products under the newly enacted Plant Protection Act, which is
part of the Agricultural Risk Protection Act of 2000. Margaret Rosso Grossman,
Biotechnology, Property Rights and the Environment, 50 AM. J. COMP. L. 215, 224
(2002).
20
Grossman, supra note 19, at 224.
21
Id.
22
Donat, supra note 9, at 428.
23
Stewart & Johanson, supra note 11, at 247.
24
15 U.S.C. § 2601 (2004).
25
7 U.S.C. § 136 (2004).
26
Grossman, supra note 19, at 224–25.
27
Donat, supra note 9, at 428.
28
Suh, supra note 1; Grossman, supra note 19, at 225 (explaining that since GM
foods are not “inherently dangerous,” no approval is required before placing them on
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is “substantially equivalent to the traditional product,” the means
used to achieve that result is immaterial in safety determinations.29
It is also optional for companies to consult the FDA before placing
GM products on the market.30 The only products that require
labeling are foods that contain common allergens.31 Nevertheless, it
is in the manufacturers’ best interests to voluntarily undergo an
FDA review of all products they intend to market because the FDA
has the authority to remove unsafe products from the market and
criminally prosecute the manufacturers of those products.32 In
addition to not requiring pre-market approval, the United States has

the market); Starla L. Borg, Waiting for the River: The United States and European
Union, Heads Up and High Strikes in the WTO–Genetically Modified Organisms in
International Trade, 43 WASHBURN L.J. 681, 715 (2004); see also Matthew Rich, The
Debate over Genetically Modified Crops in the United States: Reassessment of
Notions of Harm, Difference, and Choice, 54 CASE W. RES. L. REV. 889, 902 (2004)
(“[T]he FDA has stated that there is no material difference in nutrition, composition,
or safety between genetically modified food and non-modified food.”).
29
Donat, supra note 9, at 428. Bioengineers add fish genes to tomatoes to
prolong their freshness. Since a genetically modified tomato did not become “fishlike” and still “looks and tastes like a tomato,” the FDA states that “the only
information that will be provided to the consumer is that which is traditionally
provided with tomatoes.” See also Katharine Van Tassel, The Introduction of Biotech
Foods to the Tort System: Creating a New Duty to Identify, 72 U. CIN. L. REV. 1645,
1655 (2004).
30
Stewart & Johanson, supra note 11, at 248; Grossman, supra note 19, at 225
(stating that the FDA implemented a “voluntary consultation process,” giving
companies an opportunity to determine whether the GM food possesses unusual
attributes or substances that would warrant the need for approval of such foods before
they are placed on the market).
31
Kim Brooks, History, Change and Policy: Factors Leading to Current
Opposition to Food Biotechnology, 5 GEO. PUB. POL’Y REV. 153, 153 (2000).
However, GMOs may contaminate conventional crops that do not pose a risk of
allergies and thus create allergic reactions in people who consume foods produced
from such contaminated crops. See Wong, supra note 7, ¶ 4 (providing as an example
a year 2000 incident, when U.S. grocery stores had to recall taco shells “found to
contain genetically modified corn that was unapproved for human consumption due to
the possible allergic reactions”). In 2001, the Wall Street Journal reported that out of
twenty products labeled as “non-GMO,” sixteen contained traces of genetic
modification. The reason for this is that “some genetically modified crops—which
have been designed to resist disease, pests and chemicals—can cross-pollinate freely
with regular crops, passing along their altered traits to the next generation.” Neil E.
Harl, Biotechnology Policy: Global Economic and Legal Issues, 12 WILLAMETTE J.
INT’L L. & DISP. RES. 1, 14 (2004) (quoting Patricia Callahan & Scott Kilman, Seeds of
Doubt: Some: Ingredients Are Genetically Modified, Despite Labels’ Claims, THE
WALL ST. J., Apr. 5, 2001, at 17).
32
Stewart & Johanson, supra note 11, at 248–49.
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declined to require labeling.33 This regulatory scheme has become
known as the permissive strategy.34
Unfortunately, the U.S. government enthusiastically welcomed
GM foods without first considering the potential problems they
may cause.35 In accordance with the permissive strategy,
manufacturers often place foods derived from biotechnology on the
market before any thorough testing takes place, and government
agencies remove these foods from the market only after they find
them unsafe.36 For example, the long-term effects of many
transgenic crops, such as soybeans and corn, underwent research
and safety testing only after the widespread commercialization of
such crops.37 The lack of research and the potential harmful effects

33
See Suh, supra note 1 (stating that since the FDA considers GM foods to be
“substantially equivalent to conventional food,” there is no requirement for
manufacturers to label GM foods as such).
34
See Donat, supra note 9, at 428.
35
Some of the potential problems that arise from genetic modification of foods
include:
(1) Inadvertent creation of new allergens. “[K]nown allergens could be
transferred from traditional foods into GM foods.”
(2) Development of resistance to antibiotics. Bioengineers sometimes insert
marker genes into GM foods to help bioengineers determine “whether a new gene has
been successfully introduced to the host DNA.” If humans consume marker genes
coded for resistance to particular antibiotics, “the effectiveness of antibiotics could be
reduced and human infectious disease risk increased.”
(3) Cross-breeding. Cross-breeding between GM crops and surrounding
vegetation “could result in weeds that are resistant to herbicides and would thus
require a greater use of herbicides, which could lead to soil and water contamination.”
(4) Pesticide resistant insects. “[T]he genetic modification of some crops to
permanently produce the natural biopesticide Bacillus thuringiensis (Bt) toxin could
encourage the evolution of Bt-resistant insects, rendering the spray ineffective.”
(5) Biodiversity. “[G]rowing GM crops on a large scale may also have
implications for biodiversity, the balance of wildlife and the environment.”
(6) Cross-contamination. “[P]lants bioengineered to produce pharmaceuticals
(medicines, e.g.) may contaminate food crops.”
GM foods also present numerous ethical, religious, and philosophical concerns.
Better Health Channel, Genetically Modified Foods, http://www.betterhealth.vic.gov.
au/bhcv2/bhcarticles.nsf/pages/Genetically_modified_foods (last visited Mar. 25,
2006).
36
Brian Halweil, Portrait of an Industry in Trouble, WORLDWATCH INST., Feb.
17, 2000, http://www.worldwatch.org/press/news/2000/02/17/.
37
Id. (stating that only after more than half of the U.S. soybeans and corn were
already genetically engineered, the U.S. Secretary of Agriculture, Dan Glickman,
stated the need for long term effects of these crops on human health and the
environment).
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of GM foods before they enter the market show an alarmingly
deficient regulatory method.
B. Regulations in the European Union
In contrast to the permissive approach of the United States, the
E.U. has adopted a precautionary approach that “defines genetic
modification based on the process rather than product.”38 Therefore,
under this precautionary approach, if a crop is genetically modified
to have a longer shelf life, it is defined as genetically modified even
though it is substantially equivalent to the genetically unmodified
product. The precautionary approach has emerged from opposition
to the strong support of GM foods from the United States.39
Another fundamental difference between the permissive strategy
and the precautionary approach is that “[i]nstead of requiring critics
to prove that a technology poses potential dangers, the producers of
the technology shoulder the burden of presenting evidence that the
technology is safe.”40
As part of the precautionary strategy, the E.U. mandates
labeling of all GM products, a controversial subject that U.S.
officials view as an illegal barrier to trade.41 In fact, the United
States brought a complaint against the E.U. before the WTO
settlement committee addressing this matter.42 Brian Halweil,
speaking about the precautionary approach and the U.S. position
toward it, states:
Industry has long labeled the precautionary
approach as reactionary, arguing that it stifles
research and prevents economic progress. On the
contrary, advocates realize that all stakeholders[–
]including consumers, government, and industry[–]
benefit from an open and democratic attempt to
anticipate any undesirable social and financial
surprises. The goal is to apply wisdom and

38

Donat, supra note 9, at 429.
Michelle K. McDonald, International Trade Law and the U.S.-EU GMO
Debate: Can Africa Weather This Storm?, 32 GA. J. INT’L & COMP. L. 501, 504 (2004).
40
Halweil, supra note 36.
41
Elizabeth Suh, Opposing Views on GE Food Review, Labeling, WASH. TIMES,
Sept. 2, 2004, available at http://washingtontimes.com/upi-breaking/20040823033223-4180r.htm.
42
Id.
39
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judgment about the potential effects of a new
technology before flooding the marketplace with the
products of that technology.43
The E.U. achieves its regulation of GM foods through the legal
framework that incorporates provisions of the U.N. Codex
Alimentarius (Codex), the Cartagena Protocol to the Convention on
Biological Diversity (Cartagena Protocol), the Organization for
Economic Cooperation and Development Working Parties on
Safety of Novel Foods (OECD), and the WTO.44 The Food and
Agriculture Organization of the United Nations (FAO) and the
World Health Organization (WHO) jointly created the Codex to
develop standards for food safety and ensure fair trade practices.45
The Cartagena Protocol, enacted in 2003, is an international
agreement that establishes rules and regulations for GMO trade to
protect human health and the environment.46 The agreement insists
that countries research genetically altered organisms and assess
possible risks prior to releasing such products into the market.47
One hundred and thirty U.N. member nations have ratified the
Cartagena Protocol,48 which entered into force as a result of the

43

Halweil, supra note 36.
Compton, supra note 10, at 366. International policymakers “have attempted
to fit square pegs into round holes, applying existing trade law to the novel features of
biotechnology.” Wong, supra note 7, ¶ 2.
45
Codex Alimentarius, http://www.codexalimentarius.net/web/index_en.jsp (last
visited Mar. 7, 2006) [hereinafter Codex].
46
See Sara J. MacLaughlin, Food for the Twenty-First Century: An Analysis of
Regulations for Genetically Engineered Food in the United States, Canada, and the
European Union, 14 IND. INT’L & COMP. L. REV. 375, 402-03 (2003). The Cartagena
Protocol has the following objective:
44

[T]o contribute to ensuring an adequate level of protection in the
field of the safe transfer, handling and use of living modified
organisms resulting from modern biotechnology that may have
adverse effects on the conservation and sustainable use of
biological diversity, taking also into account risks to human
health, and specifically focusing on transboundary movements.
Cartagena Protocol on Biosafety to the Convention on Biological Diversity, art.
1, Jan. 29, 2000, http://www.biodiv.org/biosafety/protocol.asp (last visited Mar. 7,
2006) [hereinafter Cartagena Protocol]. The term living modified organism (LMO) is
interchangeable with genetically modified organism (GMO).
47
MacLaughlin, supra note 46, at 403.
48
The Cartagena Protocol has been ratified by thirty-seven African countries,
thirty-three countries of Asia and the Pacific, nineteen countries in Central and Eastern
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U.N. Convention on Biological Diversity; the United States
participated in the creation of the Convention on Biological
Diversity and signed it but has not ratified it.49 Nearly all nations
are parties to the Convention on Biological Diversity, which
negotiated the Cartagena Protocol.50 This protocol reiterates the
precautionary principle,51 embraced by European countries, that
permits countries to enact trade restrictions to avoid the adverse
effects of GMOs, even in the absence of scientific certainty with
respect to such potential adverse effects.52
The E.U. regulations governing GM products of direct interest
to the United States include Council Directive 90/220 (replaced by
2001/18/EC), which concerns “GMO products that may be
described as raw materials,” and Council Regulation 258/97, which
Europe, twenty-three countries in Latin America and the Caribbean, and twenty
countries in Western Europe and other regions. Convention on Biological Diversity,
May 15, 2000, Cartagena Protocol on Biosafety (Montreal, 29 January 2000): Status
of Ratification and Entry into Force, http://www.biodiv.org/biosafety/signinglist.
aspx?sts=rtf&ord=dt (last visited Mar. 22, 2006).
49
Id. Ratification occurs when a State “establishes on the international plane its
consent to be bound by a treaty.” Vienna Convention on the Law of Treaties, 22 May
1969, 1155 U.N.T.S. 331, 8 I.L.M. 679, 681. The concept of ratification provides the
states with the “necessary time-frame to seek the required approval for the treaty on
the domestic level and to enact the necessary legislation to give domestic effect to that
treaty.” United Nations Treaty Collection: Treaty Reference Guide, ¶18,
http://untreaty.un.org/English/guide.asp (last visited Mar. 22, 2006).
50
Olivette Rivera-Torres, The Biosafety Protocol and the WTO, 26 B.C. INT’L &
COMP. L. REV. 263, 263, 269 (2003) (stating that 186 countries are parties to the
Convention on Biological Diversity).
51
The Cartagena Protocol integrates precautionary principle through the
following language:
Lack of scientific certainty due to insufficient relevant scientific
information and knowledge regarding the extent of the potential
adverse effects of a living modified organism on the conservation
and sustainable use of biological diversity in the Party of import,
taking also into account risks to human health, shall not prevent
that Party from taking a decision, as appropriate, with regard to the
import of the living modified organism in question…in order to
avoid or minimize such potential adverse effects.
Cartagena Protocol, supra note 46, art. 10.
52
The Cartagena Protocol permits countries to limit or even prohibit the
importation of GMOs. The provision authorizing countries to restrict the importation
of GMOs has raised a controversy because the importing nations regard it as a barrier
to trade. Patrick J. Vallely, Tension Between the Cartagena Protocol and the WTO:
The Significance of Recent WTO Developments in an Ongoing Debate, 5 CHI. J. INT’L
L. 369, 372 (2004).
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concerns “‘novel foods,’ including foods containing GMOs.”53 The
purpose of Council Directive 2001/18/EC is to protect human
health and the environment in accordance with the precautionary
principle.54 It aims to accomplish that objective by “controlling
risks from the deliberate release into the environment of genetically
modified organisms….”55 The Directive requires notification before
the deliberate release of a GMO.56 It also contains a safeguard
procedure under which member states may deny consent to GM
products.57 If a member state objects to the release of GMOs, it
should submit a proposed measure to a scientific committee to
evaluate adverse effects on human health and the environment.58
The committee, “composed of individuals from all member states[,]
advises the Commission, and voting is [done] by qualified
majority.”59 The Council and the Parliament resolve any
disagreements that may arise.60 It is very important to consider that,
unlike the completely nontransparent U.S. regulations, the E.U.
Directive requires the states to consult the public about the intended
releases and give consumers an opportunity to voice their
opinions.61 Regular consumer opposition, which strives for tougher
regulation, often clashes with the anxieties of the member states’
governments that struggle to stay competitive in the field of
biotechnology. As a result, the laws frequently change and there is
no conclusive strategy.62
Council Regulation 258/97 ensures that GM foods are safe, not
misleading, and not “nutritionally disadvantageous” to consumers.63
The regulation achieves this objective through pre-market safety

53

Stewart & Johanson, supra note 11, at 256; Johannes S.A. Claus III, The
European Union’s Efforts to Sidestep the WTO Through Its Ban on GMOs: A
Response to Sarah Lively’s Paper, “The ABCs and NTBs of GMOs,” 24 NW. J. INT’L
L. & BUS. 173, 178 (2003) (describing European Union’s Directives and Regulations
that emerged in recent years in response to adverse public opinion with respect to
biotechnology).
54
Council Directive 2001/18/EC, art. 1, 2001 O.J. (L 106) 1 [hereinafter Council
Directive 2001/18].
55
Id. at (5) Preamble.
56
Council Directive 2001/18, supra note 54, art. 6.
57
Borg, supra note 28, at 717.
58
Council Directive 2001/18, supra note 54, art. 28.
59
Borg, supra note 28, at 718.
60
Id.
61
Council Directive 2001/18, supra note 54, art. 9.
62
See Stewart & Johanson, supra note 11, at 246–47.
63
Council Regulation 258/97/EC, art. 3, 1997 O.J. (L 043) 1.
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assessments of novel foods before placing them on the market.64
Furthermore, the regulation sets out the specific labeling
requirements that apply to GM foods.65 The regulation puts U.S.
exporters in distress because meeting the traceability and labeling
requirements is too burdensome under the permissive regulatory
system that exists in the United States.66
C. Recent Developments in the United States
In recent years, the United States has experienced a number of
developments in the area of GMO regulation, including the
formation of a Biotechnology Advisory Committee to review
testing and approval procedures.67 The EPA is doing a similar
review.68 There were also several lawsuits filed addressing the
developments in biotechnology. For example, a suit filed by
Greenpeace against the EPA was dismissed, and another suit
opposing the FDA’s approval of genetically altered organisms
resulted in a summary judgment for the government.69 Legislators
have also become increasingly involved in the decision-making
process regarding the regulation of GM foods.70
In 2000, President Clinton formed the U.S.-E.U. Biotechnology
Consultative Forum, consisting of “representatives of consumer
groups, academia, and industry from the United States and the
European Union,” to make recommendations regarding the
regulation of GM foods.71 The panel issued a report, recommending
“safety reviews and mandatory labeling for GMOs,” which resulted
in amplified demands to increase the regulation of the GM industry
and biotechnology as a whole.72
During the 2004 Presidential Campaign, President George W.
Bush and his challenger, Senator John F. Kerry, highlighted their
64

Id. at (2) Preamble.
Id. at art. 8.
66
Marsha Echols, Bioethics Symposium: National and Global Implications of
Genetically-Modified Organisms: Law, Ethics & Science: The WTO Biotechnology
Dispute, 34 CUMB. L. REV. 445, 445–46 (2003–04) (“While the dispute primarily pits
the United States against the European Communities, the debate in reality involves the
world and will not be resolved by these cases.”).
67
Ellison, supra note 18, at 353.
68
Id.
69
Id.
70
Id. at 360.
71
Id. at 361.
72
Id. at 361–62.
65
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differences on the issue of genetically modified crops.73 In
discussing the regulation of GMOs, Bush stressed the importance
of the “regulatory framework [that] keeps pace with science,” while
Kerry shared his plan to “give government agencies the power to
effectively regulate genetically modified food products.”74 Mindful
of the fact that the United States produces the vast majority of the
world’s genetically modified foods, President Bush argued to
protect U.S. farmers and opposed the labeling of products derived
by means of biotechnology.75 U.S. farmers largely use GM crops;
thus, the non-restrictive regulation of GM foods means higher
revenues for the farmers exporting GM crops. Conversely,
restrictions on the use of GM foods make it hard for U.S. farmers to
sell GM foods in Europe, which ends up costing U.S. farmers
millions of dollars annually.76 The approach that President Bush
argued for mirrored his father’s (former President Bush) strategy of
not requiring companies to conduct safety testing on GM foods.77
Kerry, on the other hand, promised to greatly increase government
efforts to ensure that genetically modified products are safe for
consumers as well as the environment.78 Since President Bush has
been re-elected for his second term, his policies regarding GM
foods are currently in place.
D. Recent Developments in the European Union
In 2004, European scientists concluded that GM foods are safe
for human consumption.79 Pursuant to that conclusion, in April

73

Campaign 2004 II: Bush, Kerry Face Off in Science Questionnaire,
GREENWIRE, Sept. 16, 2004, at Politics Vol.10 No.9.
74
Id.
75
Kevin Diaz, Minnesota’s Top Issues Agriculture: Farming, Biotechnology and
Trade; The Records, Opinions and Plans of the Two Leading Presidential Candidates,
STAR TRIB., Oct. 20, 2004, at 17A (stating that while GM foods yield large revenues to
American farmers, there are safety concerns associated with production and
consumption of such foods in parts of South America, Africa and Europe).
76
Brandon Mitchener, Scott Kilman & Scott Miller, EU Court Upholds Italy’s
Ban on Genetically Modified Food, WALL ST. J., Sept. 9, 2003, available at
http://www.mindfully.org/GE/2003/EU-Italy-Ban-GMO9sep03.htm.
77
Hart, supra note 5, ¶ 8.
78
Diaz, supra note 75 (Kerry promised to push for acceptance of American
exports of GM foods and mindful of safety concerns, “Kerry has also criticized the
Europeans and others who he says should not use safety as a ‘pretext’ to close their
markets to U.S. exports.”).
79
Meller, supra note 15.
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2004, the European Commission lifted a moratorium on the
importation of GM foods that had been in effect for the past six
years.80 However, the E.U. remains firm on the labeling issue, and
prior to lifting the moratorium, the European Commission passed
strict laws mandating labeling of GM foods.81 The new regulations
include Regulation (EC) No. 1829/2003, dealing with GM food and
feed, and Regulation (EC) No. 1830/2003, dealing with traceability
and labeling of GM foods.82 The objective of both regulations is to
“protect the environment, human and animal welfare
and…consumer choice.”83
In September 2004, the E.U., for the first time, approved the
planting and selling of certain seeds derived by biotechnological
means in Europe.84 The E.U. made the decision in spite of
widespread opposition by European consumers.85 Nevertheless,
support for GM foods in the E.U. continues to grow. The Danish
nominee for the post of the European Agriculture Commissioner,
Mariann Fischer Boel, expressed her support for both GM and
conventional (including organic) foods by stating that “no form of
agriculture (GMO or non-GMO) should be excluded in the EU in
the future.”86
E. The Role of the World Trade Organization
Existing regulations cannot keep up with rapidly developing
technology. Because neither the supporters nor the opponents of
GM foods are willing to give in, there is a great need for a
common-ground, international regulatory scheme that would take
both the objectives of international trade and the need to protect
human health and the environment into consideration.
Traditionally, these two interests have clashed, and therefore “the
question which must be addressed by future policy makers is not
80

Id.
Id.
82
Brian Schwartz, Student Note, WTO and GMOs: Analyzing the European
Community’s Recent Regulations Covering the Labeling of Genetically Modified
Organisms, 25 MICH. J. INT’L L. 771, 781 (2004). Both regulations went into effect on
April 18, 2004. Regulation (EC) No. 1829/2003 preempts the provisions of the
Council Regulation 258/97 (Novel Foods Regulations) that deal with GM foods. Id.
83
Id. at 783.
84
EU Approves GMO Seed, supra note 16.
85
Id.
86
Sara Lewis, Incoming EU Farm Commissioner Calls for Biotech Coexistence,
46 FOOD CHEMICAL NEWS, Sept. 27, 2004, at 10.
81
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which aspect should prevail, but rather how to create harmony
between the two.”87 Achieving such balance will not be easy, but
because the industry is so new, there is “a unique opportunity to
tailor regulatory requirements closely to the needs of the time and
to find a sensible balance between the concerns of the industry,
government, science, and the public.”88 The organization that
should play a central role in achieving a higher level of
understanding between the advocates and the critics is the WTO.
The WTO has established procedures by which countries can
notify it if certain measures taken by member states may potentially
affect international trade.89 If such measures are in violation of
WTO trade rules, the WTO may impose trade sanctions.90 Two
mutually exclusive WTO agreements deal with GM foods: the
Agreement on the Application of Sanitary and Phytosanitary
Measures (SPS Agreement), and the Agreement on Technical
Barriers to Trade (TBT Agreement).91 The goal of the TBT and SPS
Agreements is to advance trade and expound the General
Agreement on Tariffs and Trade (GATT).92
The SPS Agreement was implemented in 1995 to prevent
certain scientifically unfounded safety measures from impeding the
trade of food products.93 While the SPS Agreement “permits
countries to maintain SPS measures necessary to protect human,
animal, and plant life and health,” it also facilitates trade by
requiring that such protective measures are not used “as disguised
barriers to trade.”94 The SPS Agreement promotes conformity of
national measures with international standards and encourages

87

Jennifer A. Bernazani, The Eagle, the Turtle, the Shrimp and the WTO:
Implications for the Future of Environmental Trade Measures, 15 CONN. J. INT’L L.
207, 208 (2000).
88
Frederick H. Degnan, The Food Label and the Right-to-Know, 52 FOOD &
DRUG L.J. 49, 49 (1997).
89
Compton, supra note 10, at 372.
90
Id. at 372–73
91
Id. at 373–74.
92
Norbert L.W. Wilson, Clarifying the Alphabet Soup of the TBT and the SPS in
the WTO, 8 DRAKE J. AGRIC. L. 703, 705 (2003).
93
Terence P. Stewart & David S. Johanson, A Nexus of Trade and the
Environment: The Relationship Between the Cartagena Protocol on Biosafety and the
SPS Agreement of the World Trade Organization, 14 COLO. J. INT’L ENVTL. L. &
POL’Y 1, 25 (2003).
94
Id.

325

I NTERNATIONAL L AW & M ANAGEMENT R EVIEW

V OLUME 2

countries to enact measures based on an international standard.95
The SPS Agreement also provides for another way of establishing
SPS measures by basing them on risk assessment.96 Risk
assessment bases itself on the following factors: “available
scientific evidence; relevant processes and production methods;
relevant inspection, sampling and testing methods; prevalence of
specific diseases or pests; existence of pest- or disease-free areas;
relevant ecological and environmental conditions; and quarantine or
other treatment.”97 Lastly, countries can also enact provisional SPS
measures “on the basis of available pertinent information.”98
The TBT Agreement “encourages the development of
international regulatory standards” and prevents deceptive
practices.99 It requires that measures “are not applied in a manner
95

Id. at 26. Scientific justifications may warrant higher standards that are stricter
than the international norm. Borg, supra note 28, at 689. Under the SPS Agreement,
scientific justifications also permit countries to implement measures that are “neither
based on, nor exceed international standards.” Rivera-Torres, supra note 50, at 296.
96
Article Five of the SPS Agreement provides: “[m]embers shall ensure that
their sanitary or phytosanitary measures are based on an assessment, as appropriate to
the circumstances, of the risks to human, animal or plant life or health, taking into
account risk assessment techniques developed by the relevant international
organizations.” The WTO Agreement on the Application of Sanitary and
Phytosanitary Measures, Apr. 15, 1994, art. 5(1), http://www.wto.org/English/tratop_
e/sps_e/spsagr_e.htm (last visited Mar. 22, 2006) [hereinafter SPS Agreement].
97
Id. at art. 5(2).
98
Article Five of the SPS Agreement provides:
In cases where relevant scientific evidence is insufficient, a
Member may provisionally adopt sanitary or phytosanitary
measures on the basis of available pertinent information, including
that from the relevant international organizations as well as from
sanitary or phytosanitary measures applied by other Members. In
such circumstances, Members shall seek to obtain the additional
information necessary for a more objective assessment of risk and
review the sanitary or phytosanitary measure accordingly within a
reasonable period of time.
Id. at art. 5(7).
99
Borg, supra note 28, at 693. The TBT Agreement sets the following standards:
Members shall ensure that technical regulations are not prepared,
adopted or applied with a view to or with the effect of creating
unnecessary obstacles to international trade. For this purpose,
technical regulations shall not be more trade-restrictive than
necessary to fulfil [sic] a legitimate objective, taking account of
the risks non-fulfilment [sic] would create. Such legitimate
objectives are, inter alia: national security requirements; the
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[that] would constitute a means of arbitrary or unjustifiable
discrimination between countries where the same conditions prevail
or a disguised restriction on international trade.”100 Risk assessment
under the TBT Agreement shall base itself on the following factors:
“available scientific and technical information, related processing
technology or intended end-uses of products.”101 Article 1.5 of the
TBT Agreement limits its scope by stating that the agreement does
not apply to sanitary and phytosanitary102 measures, thus making
the TBT and the SPS Agreements mutually exclusive.103
The GATT, first signed in 1947, regulates tariffs on goods and
provides a forum for settling trade disputes, thus encouraging free
trade between member states.104 The framework for free trade under
GATT is built upon the following three principles: “prohibiting
discrimination between the products imported by member states,”
“prohibiting discrimination between imported and domestic goods,”
and “prohibiting quantitative restrictions on trade.”105 GATT
Article XX sets forth general exceptions to unrestricted trade,
which include measures “necessary to protect human, animal or
plant life or health.”106 However, even if the exception is made in
accordance with Article XX provisions, it still “shall not depart
from the provisions of this Agreement relating to nondiscrimination.”107
Clearly, all WTO agreements aim at facilitating trade and
requiring countries to restrain from imposing measures that will

prevention of deceptive practices; protection of human health or
safety, animal or plant life or health, or the environment.
Agreement on Technical Barriers to Trade, Apr. 15, 1994,
http://www.worldtradelaw.net/uragreements/tbtagreement.pdf (last visited Mar. 25,
2006) [hereinafter TBT Agreement].
100
Id. at Preamble.
101
Id. at art. 2.2.
102
Phytosanitary is defined by Merriam-Webster as “of, relating to, or being
measures for the control of plant diseases especially in agricultural crops.”
103
Article 1.5 of the TBT Agreement reads: “[t]he provisions of this Agreement
do not apply to sanitary and phytosanitary measures as defined in Annex 4 of the
Agreement on Application of Sanitary and Phytosanitary Measures.” TBT Agreement,
art. 1.5.
104
See Rivera-Torres, supra note 50, at 289.
105
See id.
106
General Agreement on Tariffs and Trade, Oct. 30, 1947, 61 Stat.A-11, 55
U.N.T.S. 194 at art. XX., available at http://www.ciesin.org/TG/PI/TRADE/gatt.html
(last visited Mar. 22, 2006) [hereinafter GATT].
107
Id. at XX(i).
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restrict the transboundary movement of goods.108 Conversely, the
Cartagena Protocol, concerned with the environment, requires
states to take affirmative steps to regulate GMOs appropriately in
ways that ensure the preservation of biodiversity.109 As a result,
there is a risk that measures enacted under the Cartagena Protocol
would deviate from the WTO rules. To prevent measures enacted
under the Cartagena Protocol from being invalidated as
unreasonable barriers to trade, such measures must comply with the
international standards provided for by the WTO.110 Moreover,
when disputes are resolved through the WTO Dispute Settlement
Procedures, “environmental treaties may be invalidated as trade
barriers, as they are not considered when all GATT parties have not
approved of their recognition.”111
In 2001, the Commission of the European Community proposed
regulations “concerning traceability and labelling [sic] of
genetically modified organisms.”112 The objectives of the proposed
regulations are to facilitate quality control, to provide a “safety net”
in all stages of production and marketing, and to create mechanisms
for removing unsafe foods from the market.113 The proposal also
creates a framework for controlling labeling and verifying claims
made on food labels.114 The proposed regulations “provide legal

108

See Rivera-Torres, supra note 50, at 302.
Id.
110
Borg, supra note 28, at 696 (stating that unless environmental measures are
enacted in accordance with the international standard recognized by the WTO, “the
environmental mission may be seen as irrelevant and, in some instances, as an
obstruction to free trade”).
111
Id.
112
Commission Proposal for a Regulation of the European Parliament and of
the Council Concerning Traceability and Labelling [sic] of Genetically Modified
Organisms and Traceability of Food and Feed Products Produced from Genetically
Modified Organisms and Amending Directive 2001/18/EC, at 9, COM (2001) 182
final (July 25, 2001), available at http://europa.eu.int/comm/food/fs/biotech/
biotech09_en.pdf [hereinafter Proposal for Traceability and Labeling of GMOs]. In
the explanatory section of the proposal, it is recognized that disparities between laws
of different exporting and importing countries with regard to GM food regulation
“may hinder the free movement of products, creating conditions of unequal and unfair
competition.” The proposal remedies this problem by creating a coherent and
consistent framework for tracing and labeling GM foods. Id.
113
The traceability requirements allow for continued tracking of products
containing GMOs and ensure that such information is retained through every stage of
placing the product of the market and never discontinued. Id. at 8.
114
All GM products placed on the market have to carry a label saying “[t]his
product contains genetically modified organisms.” In the case of impossibility of
109
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certainty for traders” and ensure “that ethical, legal, social and
wider cultural aspects are taken into account in policy-making and
research funding.”115
The United States did not favor the proposal, and in a secret
document sent to the WTO, the United States subjected it to vast
criticism calling into question the majority of its objectives.116 The
United States expressed concerns that the proposed regulation was
“not workable or enforceable, would be very expensive to
implement, and would not achieve the stated objectives.”117 The
United States opposed labeling on the grounds that it would do
“nothing to ensure food safety,” would “encourage[] fraudulent
labelling [sic] claims,” and “would undermine consumer
confidence.”118 Moreover, the proposed regulation “would be
disastrous for U.S. farmers” and would “disrupt market access from
Europe’s major trading partner and from developing countries,
again stifling development of the technology.”119

placing a label directly on a product, appropriate documentation should accompany
the product. Id. at 7.
115
Biotechnology: National Rules to Resolve Problem of Co-Existence of Crops,
EUROPEAN REPORT, Mar. 8, 2003, at 3.
116
See U.S. Comments: Proposal for a Regulation of the European Parliament
and of the Council Concerning Traceability and Labeling of Genetically Modified
Organisms and Traceability of Food and Feed Products from Genetically Modified
Organisms and Amending Directive 2001/18/EC (Dec. 6, 2001), available at
http://www.foeeurope.org/press/USG_comments_G_TBT_N_EEC_7.pdf [hereinafter
U.S. WTO TBT Response].
117
Id. Consider the following example:
A medium sized food company can have more than 6,000 products
that contain 8,000 ingredients from 1,000 suppliers that move
through 30 processing plants on their way to being exported to as
many as 100 countries. Implementing a system to track all of these
ingredients from their source (as far back as to the farm) to the
final destination is a daunting task that would cost billions of
dollars and even then it may not be infallible.
Mystery Bridges, Genetically Modified Organisms and the Precautionary
Principle: How the GMO Dispute Before the World Trade Organization Could Decide
the Fate of International GMO Regulations, 22 TEMP. ENVTL. L. & TECH. J. 171, 178
(2004).
118
Press Release, Friends of the Earth, U.S. Steps up the Pressure on EU GMO
Legislation (Jan. 16, 2002), available at http://www.genet-info.org/genet/2002/Jan/
msg00021.html [hereinafter EU GMO Legislation].
119
Alan Larson, The Future of Agricultural Biotechnology in World Trade: The
Promise and Challenges, Feb. 21, 2002, http://www.state.gov/e/rls/rm/2002/8447.htm.
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Instead, the United States favors a less restrictive system that it
has followed for years.120 Under that system, instead of
communicating the biotech information to all the recipients of the
GM products, such products would simply be recalled from the
market if a valid safety concern arose.121 In other words, the United
States considers foods derived from biotechnology to be safe until
proven harmful.122 Labeling, in the view of the United States, is too
burdensome, and it is not in any country’s interest because it
“encourages fraudulent claims.”123 Moreover, the United States
argues that this regulation would do nothing to protect consumers
and instead would “discourage trade and increase delays and
liability costs for exporters, EU importers, and processors.”124
The U.S. criticism of the proposed regulation caused a huge
wave of frustration and resentment in the European countries.125
Friends of the Earth food campaigner, Adrian Bebb, expressed this
intensifying sentiment in response to the U.S. comments:
The Bush Administration is trying to take away our
right to decide on GM food. The public has made it
very clear that they want proper labelling [sic] and
proper testing for GM foods. The proposed EU laws
are at least a step in the right direction. The US
wants to weaken these laws to protect the likes
of…American agri-business. European countries
must refuse to bow to this bullying. European
citizens demand the right to choose.126

120

See U.S. WTO TBT Response, supra note 116.
Id.
122
Halweil, supra note 36 (discussing the fundamental differences between the
permissive approach, applied in the United States, and the precautionary principle,
followed in Europe and many other countries, with respect to GM food regulation).
123
U.S. WTO TBT Response, supra note 116.
124
Id.
125
See EU GMO Legislation, supra note 118.
126
Press Release, Friends of the Earth, U.S. Steps Up Pressure on GM Food: US
Threatens the Public’s Right to Choose on GM Food (Jan. 16, 2002), available at
http://www.foe.co.uk/resource/press_releases/20020116125140.html. European consumers are not the only ones demanding the right to choose. In addition to the E.U.
member countries, Japan, South Korea, Australia, Mexico, and other nations enacted
laws mandating labeling of foods containing genetically modified ingredients.
Halweil, supra note 36.
121
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The U.S. view focuses more on the development and marketing
of biotechnology rather than on testing for possible risks it may
pose, which demonstrates misplaced priorities and poor planning.127
The position of the E.U. is that it “should not have to suffer for
incorporating the precautionary principle into its regulation from
the beginning simply because of decisions made by the [United
States].”128
The disputes involving WTO regulations are settled through the
well-established WTO Dispute Settlement Process.129 Although the
WTO usually favors U.S., European, and Japanese businesses, there
is a growing concern that it tends to render more support to the
United States than to other countries. As a result, European
corporations are having a harder time trying to produce safer
foods.130 In fact, some have accused the WTO of being a “cat’s paw
of the United States government” for frequently siding with U.S.
businesses in spite of disapproval of European resistance to
GMOs.131
Recently, at the request of the United States, Canada, and
Argentina, the WTO agreed to investigate the E.U.’s position on
GMOs.132 The WTO organized a three-judge panel in August
2003133 and should have issued its report on January 5, 2006.134
However, two days before the panel issued its scheduled report, the
panel’s chair announced that the interim preliminary report would

127

Bridges, supra note 117, at 178–79.
Id. at 179.
129
Stewart & Johanson, supra note 93, at 26. Among the disputes involving SPS
measures, “three…have reached the Dispute Settlement Body, five are pending
consultations, and two have been settled.” Id.
130
See Anup Shah, A Huge Wave of Public Concern, http://www.globalissues.
org/EnvIssues/GEFood/PublicReaction.asp (last visited Mar. 23, 2006).
131
John Moore, John Moore Urges Us to Assert Our Right to Economic and
Cultural Diversity and Stand Up to the Unaccountable WTO, MORNING STAR, Oct. 4,
2004, at 9.
132
Europe Reflects Italian Battle over Biotech Coexistence, ANSA ENGLISH
MEDIA SERVICE, Oct. 13, 2004, 2004 WL 86476169 [hereinafter Europe Reflects
Italian Battle]. In response to the moratorium on the importation of GMOs imposed by
the E.U., the United States, joined by Argentina and Canada, initiated a Dispute
Settlement Process through the WTO. The negotiation deadlocked, and after 60 days,
a panel was appointed to adjudicate on the issue of the E.U.’s de facto ban on GM
foods. Wong, supra note 7, ¶1.
133
Europe Reflects Italian Battle, supra note 132.
134
GMO Update: WTO Biotech Case, ISAAA, EU, APEC, 6 BRIDGES TRADE
BIORES 1, Jan. 20, 2006, available at http://www.ictsd.org/biores/06-0120/story3.htm.
128
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not be issued until February 2006.135 One commentator compared
the WTO with the game of poker, where “every player must be
aware of the rules and work within their confines in order to
succeed.”136 He added that “[w]hile each player is familiar with the
house rules, whether the WTO is equipped to handle genetic
engineering concerns remains to be seen.”137
While the decision is pending, certain predictions can be made
based on precedents. In 1997, the WTO supported the U.S. position
in the dispute that arose between the United States and the E.U.
over the European ban on the importation of beef containing
synthetic growth hormone that farmers had administered to cows to
enhance their growth.138 The WTO ruled that the European ban was
not based “on scientific evidence, risk assessment, or relevant
international standards….”139 Still, the issue of the E.U.’s ban on
GMOs is not a clear-cut case for the United States because the
WTO will have to decide whether the E.U.’s GMO restrictions fit
into a GATT Article XX exception for the protection of “human,
animal, or plant life or health.”140 Even though the precautionary
principle adopted by the E.U. had little support in WTO precedents,
it can potentially be considered as customary international law, and

135

Id.
Borg, supra note 28, at 696–97.
137
Id. at 697.
138
Wilson Huhn, Three Legal Frameworks for Regulating Genetic Technology,
19 J. CONTEMP. HEALTH L. & POL’Y 1, 34–35 (2002). Certain socio-political factors
may account for the differences between the U.S. and E.U. positions:
136

The United States, an individualistic society with a capitalistic
economy, is likely to continue to approach [the] issues [of
biotechnology] from a rights or a scientific regulation perspective,
while more communitarian societies that have a stronger
commitment to traditional values will opt for a stricter regulatory
regime or for legislative preemption. National preferences for
different models of regulation will hamper the development of a
rational and comprehensive scheme of international regulation of
biotechnology.
Id. at 35.
Id. at 34. The WTO ordered the E.U. to pay the United States over US$100
million in damages that incurred as a result of the ban on the importation of hormonetreated beef. Id. at 35.
140
Bridges, supra note 117, at 183 (quoting TBT Agreement, supra note 99, at
preamble).
139
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as such, the WTO cannot ignore it.141 Accordingly, there is a sound
possibility that the WTO will uphold E.U. restrictions on the
importation of GMOs.
III. POLITICAL AND SOCIAL CONTEXT OF GMO REGULATIONS
AND CONFLICTING PRIORITIES BETWEEN
THE UNITED STATES AND THE EUROPEAN UNION
Biotechnology is young and developing at a rapid pace, making
it hard for consumers and governments worldwide to adjust.142
Consumer groups are putting pressure on the FDA “to require
mandatory, transparent reviews and appropriate labeling….”143 The
movement seems to echo the European trend of opposing
biotechnology.144
At the root of this disagreement are a number of clashing legal
principles and cultural values between the United States and the
E.U. member-states. The United States has been at the forefront of
biotechnological developments and one of the first countries to
apply them to agricultural industry, harvesting GM crops on
millions of acres of land.145 Accordingly, liberal regulations of GM
foods in the United States derive from the profound interest of the
government and businesses in international exports of these
advanced crops.146 Furthermore, lobbyists for the GE industry
greatly influence agricultural departments who receive financial
incentives to promote the GE industry.147
The members of the E.U., however, do not share this attitude.
They follow a more cautious approach and implement significant
restrictions on imports of GM foods as well as rigid labeling
standards.148 Due to safety concerns, the E.U. member states and

141
Id. at 184 (arguing that because the precautionary principle is used worldwide
in cases of scientific uncertainty, “the WTO should accept the EU’s restrictions as
necessary and reasonable” because the E.U. used the precautionary principle to design
their GMO regulations).
142
Compton, supra note 10, at 364–65.
143
Suh, supra note 1.
144
Id. Labeling has been or is likely to be adopted by about forty-eight countries.
See Harl, supra note 31, at 4.
145
Compton, supra note 10, at 365.
146
Id.
147
Shah, supra note 130.
148
Compton, supra note 10, at 365.
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many other WTO members enacted trade restrictions on the
importation of GM foods.149
There is a difficult controversy over the need to provide
safeguards due to the lack of knowledge regarding the long-term
effects of biotechnology.150 Scientific studies have exposed certain
risks to humans, such as allergic reactions, and more potential
harms may exist.151 Risks to the environment also remain uncertain.
Although many speculations take place in the scientific community,
some predict unintended, permanent damage to our ecosystem.152
Supporters, however, say that the known benefits of biotechnology
outweigh the potential risks.153 They also stress the need to use
biotechnology to help developing countries fight hunger and
malnutrition.154
A range of cultural values also need to be taken into
consideration. Even if GM foods were safe in every aspect and
safety was not an issue, disagreements regarding the use of
biotechnology would probably not cease.155 Many attitudes toward
biotechnology are based on cultural values and ethical concerns,
and certain countries may have “a real, but unquantifiable,
unverifiable, non-science-based aversion to a certain product.”156
When the United States embraced biotechnology, many foreign
consumers vehemently voiced their opposition based not only on
safety, but also on their uneasiness with the idea that U.S.
corporations would “dare to ‘play God’ by altering the genetic
make-up of plants.”157 Many people are uncomfortable with change.

149

McDonald, supra note 39, at 503–04.
Id. at 504.
151
Id.
152
Id.
153
See id. at 520.
154
Id. at 521.
155
Frank Loy, Genetically Modified Organisms: Colloquium Article Statement
on Biotechnology: A Discussion of Four Important Issues in the Biotechnology
Debate, 8 N.Y.U. ENVTL. L.J. 605, 605 (2000).
156
Id.
157
Brooks, supra note 31, at 154. Europeans express ethical concerns regarding
biotechnology because they feel that “genetic modification or engineering of crops is
not a natural extension of traditional plant breeding techniques as it violates a ‘natural
order’ which should be respected and not violated.” Wong, supra note 7, ¶ 6.
Proponents of biotechnology, however, say that genetic modification is just a modern
form of selective breeding, in which people have engaged for centuries and which has
proven to be safe. Rich, supra note 28, at 890. See Thomas O. McGarity, Seeds of
Distrust: Federal Regulation of Genetically Modified Foods, 35 U. MICH. J.L.
REFORM. 403, 427 (2002) (arguing that unlike traditional breeding that “take[s]
150
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Because scientific evolution has been so rapid, people’s mentalities
have not had enough time to adjust. The United States greatly relies
on technology, which may help explain why people in the United
States are more comfortable with biotechnology than people in
other countries who do not have the same trust for or reliance on
technology.158
A number of other theories exist that help explain the reasons
for public opposition to biotechnology in Europe. In recent years,
for example, Europe has suffered a number of health scares, such as
the “mad cow disease” and dioxin-tainted products.159 Epidemics of
this kind naturally make consumers anxious about the foods placed
on the market, especially when those foods are novel and
controversial. Alternately, European apprehension over GM foods
may stem from the “more enduring ties between urban populations
and agriculture and food products.”160 Europeans conceptualize
food in a way that attaches symbolic value to it. “In many European
countries there is a strong link between culture and food…David
Byrne, the EU Health and Consumer Safety Commissioner, has
said, referring to food quality, that ‘[f]or some member states it’s
nearly synonymous with sovereignty.’”161 As a result, “the degree
of risk of GM food products may not be as important…as the fact
that this risk touches something of great symbolic importance,”
rather than just “a means of survival.”162 Still some hold that the
advantage of nature’s vast storehouse of information”, biotechnology accomplishes
changes “that could never occur in nature”). Consequently, “[b]ecause modern genetic
engineering is a hit-or-miss process that ‘disrupts the existing genome in a random
way,’ it is more likely to create unexpected, unintended side effects than the
conventional approaches.” Id. at 427–28. Furthermore, “[t]he new technology allows
for a far greater number of organisms to be produced at a far greater speed compared
to traditional methods, and the collective impact of these organisms presents problems
for risk assessment.” Rich, supra note 28, at 891. Contra J. Howard Beales III,
Modification and Consumer Information: Modern Biotechnology and the Regulation
of Information, 55 FOOD & DRUG L.J. 105, 105–06 (2000) (arguing that genetic
engineering is “not fundamentally different from old methods of selective breeding”).
158
Brooks, supra note 31, at 162.
159
Emily Marden, Risk and Regulation: U.S. Regulatory Policy on Genetically
Modified Food and Agriculture, 44 B.C. L. REV. 733, 744 (2003).
160
Id.
161
Brian P. Rafferty, The Door Opens Slightly: Recent European Union
Regulations on Genetically Modified Products and the Ongoing United StatesEuropean Union GM Product Dispute, 16 GEO. INT’L ENVTL. L. REV. 281, 295 (2004)
(quoting Lizette Alvarez, Consumers in Europe Resist Gene-Altered Foods, N.Y.
TIMES, Feb. 11, 2003, at A3) (discussing the roots of the European views on GM
food).
162
Id. at 295.
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European objection to biotechnology is “simply an indirect route
for rejecting American corporate arrogance.”163 In all likelihood,
however, no single factor is responsible for the European reaction
to genetic engineering and many different variables contribute to
that attitude.164
In August 2003, the OECD held a biotechnology conference in
Europe.165 The conference report listed the issues of general
agreement as well as the more controversial issues that did not
reach agreement.166 The parties did, however, reach a consensus
regarding the need for more public discussion as well as research.167
The areas of disagreement included moral issues, environmental
concerns, and mandatory labeling of GM foods.168 Authors of a
paper written for the biotechnology conference stressed the need
for a long-term strategy and proposed a “holistic approach” that
would benefit the industry, the science, and the consumers.169 They
remained optimistic that the European public would warm up to
biotechnology, as long as effort was put into rebuilding consumer
confidence, which is what the industry is trying to do by
introducing new products that will benefit the public.170
IV. THE NEED FOR MORE PUBLIC DISCUSSION IN THE DECISIONMAKING PROCESS AND THE IMPORTANCE OF INFORMED
CONSUMER CHOICE
Studies on consumer perception show that support for GM
foods has declined due to the weakening of consumer trust in
governmental regulation.171 No matter how much money gets
pumped into the GE industry, “developers and producers’ money
and efforts are wasted if consumers lack confidence in the
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Marden, supra note 159, at 744–45.
Id. at 745.
165
Compton, supra note 10, at 370.
166
Id. at 370–71.
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Id. at 370.
168
Id. at 370–71.
169
John Mason, European Consumers Put Up Tough Fight: Genetically
Modified Food: The Debate About GM Food Is More Heated in the UK and the Rest
of Europe Than It Is Elsewhere, FIN. TIMES (London), Sept. 8, 2004, at 4.
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Id.
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See Compton, supra note 10, at 365 (2003) (interpreting the studies by
Thomas Hoban, professor of sociology and food science at North Carolina State
University in Raleigh).
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product.”172 Accordingly, the “consumer right-to-know” is at the
core of the GM controversy.173
A. Informed Consumer Choice Issues in the United States
The Federal Food, Drug and Cosmetic Act of 1938 (“FDCA”)
prohibits misbranding and misleading representations about food
and requires that certain essential information be included on a
label.174 Specifically, five pieces of information are required: (1)
“the name and place of business of the manufacturer, packer, or
distributor;” (2) “an accurate statement of the quantity of the
contents in terms of weight, measure, or numerical count;” (3) “the
common or usual name of the food;” (4) “the common or usual
name of each…ingredient” (if two or more ingredients are used);
and (5) a label containing complete nutritional information.175 The
purpose of the label is to provide consumers with essential
information about the food, but due to the limited space on a label,
the FDA only requires the inclusion of crucial information.176 The
FDA does not consider information on genetic modification crucial,
thereby influencing its view that the FDCA does not require the
labeling of foods derived from biotechnology.177 Moreover, in spite
of consumer demands for more information regarding genetic
engineering, the FDA argues that including such information would
only clutter food labels with unnecessarily confusing messages and
thus decrease the effectiveness and utility of labeling.178 For this
reason, the agency is even wary of voluntary labeling of GM foods
because it can potentially mislead consumers who, due to lack of
information, may assume that genetic engineering results in unsafe
foods, thereby deterring people from purchasing foods that may, in
fact, have higher nutritional value than conventional foods.179
Accordingly, the FDCA condemns statements they consider
172
Christine Cochran, Premarket Notice Concerning Bioengineered Foods: A
Proposed Regulation Satisfying Some of the Players, Some of the Time, 12 WASH. U.
J.L. & POL’Y 173, 200 (2003) (suggesting that the government, producers, and
developers of GMOs should put efforts into educating the public about biotechnology
before fear of the unknown causes the public to completely reject it).
173
Degnan, supra note 88, at 50.
174
21 U.S.C. § 343 (2004).
175
21 U.S.C. § 343(e),(i),(q) (2004).
176
Degnan, supra note 88, at 55.
177
Id.
178
Id. at 55–56.
179
See id. at 49.
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misleading, even when ambiguity results from “the use of
statements not technically false or which may be literally true.”180
Perhaps, a seemingly better solution would be to educate the public
rather than to carefully craft the food labels in a way that shields
consumers from the information that would allow them to make
wise, educated decisions and shop with confidence.
The industry’s resistance to labeling is not the only hurdle
consumers have to overcome before succeeding in convincing
Congress to give the FDA authority to mandate labeling; there are
also important constitutional issues at hand. Even if the FDA had
authority to mandate labeling, the Supreme Court may hold such
requirement unconstitutional with regard to commercial speech.181
Commercial speech is protected by the First Amendment, and such
speech may only be compelled if a substantial governmental
interest is present.182 Mere consumer desire for more information to
satisfy curiosity does not rise to the level of a compelling
governmental interest under constitutional scrutiny.183 However, it
is not mere curiosity, but health concerns and potential
environmental risks that guide many consumers to pursue
mandatory labeling.184 Even these concerns, however, are not likely
to be enough to meet the required threshold of scrutiny because of
the present consensus between the FDA and the National Academy
of Sciences, which concludes that foods derived by means of
biotechnology do not differ substantially from traditional
products.185
A case that illustrates this constitutional issue is International
Dairy Foods Ass’n[BB 10.2.1(c)] v. Amestoy, 92 F.3d 67 (1996),
where dairy manufacturers challenged the constitutionality of a
Vermont statute requiring identification of milk products that came
from cows that were given bovine growth hormone (“rBST”) to
increase milk production.186 The Second Circuit Court of Appeals
180
United States v. Ninety-Five Barrels (More or Less) Alleged Apple Cider
Vinegar, 265 U.S. 438, 443 (1924). In this case, a manufacturer was charged with
misbranding of vinegar produced from dried apples as “apple cider vinegar.” Id. at
439. The U.S. Supreme Court found that the label was misleading and therefore the
vinegar was misbranded. Id.
181
Jonathan Adler, Regulating Genetically Modified Foods: Is Mandatory
Labeling the Right Answer?, 10 RICH. J.L. & TECH. 14, ¶ 1 (2004).
182
Id. ¶ 6.
183
Id. ¶ 8.
184
Id.
185
Id.
186
Int’l Dairy Foods Ass’n v. Amestoy, 92 F.3d 67, 69–70 (2d Cir. 1996).
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held that since rBST-derived milk was undistinguishable from
regular milk, and since Vermont could not prove the existence of
harm, the State of Vermont could not compel the dairy
manufacturers to “speak against their will.”187 The court further
stated that “consumer curiosity alone is not a strong enough state
interest to sustain the compulsion of even an accurate, factual
statement.”188 “[T]he government must have…a substantial
governmental interest to infringe upon commercial speech,” such as
“unidentifiable health risks, an economic impact, or a physical
impact on the consumer.”189 This is a difficult burden to overcome
to justify labeling when all the regulatory agencies are in consensus
about the safety of GM foods.190 However, if proponents narrowly
tailored labeling requirements, such as applying it to potentially
allergenic products, the requirements may pass the threshold of
constitutionality.191
There may be other considerations about mandatory labeling
that would give grounds to a constitutional barrier:
[T]he GM debate…is mostly about values and about
ethical concerns. This fact raises an additional red
flag under the First Amendment because the Court
has always been very sensitive to the idea that
compelling an individual to give voice to a
controversial message, or to make a statement with
which they disagree, is something that the
government should rarely be allowed to do….
A GMO labeling requirement would be likely to
face additional scrutiny because there would be real
suspicion that the basis for the labeling is not health
concerns, but political control over the sorts of
messages and values that we communicate in the
food distribution process and in the food market
process. In that context, courts have made it clear
that those are the sorts of debates that the

187
188
189
190
191

Id. at 74.
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Adler, supra note 181, ¶ 7.
Id. ¶ 8.
See id. ¶ 11.
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government should stay out of and should be left to
the market place of ideas.192
Admittedly, even though biotechnology carries potential risks,
the constitutional protection on commercial free speech makes it
very difficult to impose mandatory labeling in the United States,
absent any explicit evidence of real harm. Despite the possible
constitutional barrier, if the public applies enough pressure, there
are “other non-governmental labeling schemes which can rise up
and provide consumers with the sort of information that they may,
for very good reasons, feel that they want or need when they are
deciding what products to buy.”193
Eventually, changes will likely take place because of growing
consumer demands for information, irrespective of the safety issue.
Seventy-five percent of the respondents of the Pew poll in 2001
pointed to the importance of being aware of the presence of GM
ingredients in their food.194 In 2003, eighty-nine percent of poll
respondents expressed the need for mandatory FDA review before
the marketing of GM products.195 In 2002, a bill was introduced in
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Id. ¶ 16.
194
Suh, supra note 41. See Cynthia D. Fisher, The Genie Is Out of the Bottle:
Consumers Demand Mandatory Labeling on Genetically Engineered Foods, 4 J.
LEGAL ADVOC. & PRAC. 88 (2002). Other polls report similar findings:
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In June 2001, an ABC News telephone poll revealed that ninetythree percent of American people support labeling genetically
engineered (“GE”) foods, and fifty-two percent believe GE foods
are unsafe. Time Magazine similarly reported that eighty-one
percent of Americans polled support mandatory labeling of GE
foods. The Center for Food Safety, a Washington D.C. scientific
thinktank and grassroots forum for litigation support and
dissemination of issues surrounding food safety, provides a
comprehensive report of polls taken throughout the United States.
This investigation revealed an overwhelming demand for
mandatory labels on GE foods. Such studies show that while
consumers are generally not opposed to GE foods, they are
adamantly against allowing such foods to be sold without adequate
labeling.
Id.

195
Suh, supra note 41 (discussing a recent Pew poll where respondents were
asked to evaluate the statement: “[c]ompanies should be required to submit safety data
to the FDA for review, and no genetically modified food product should be allowed on
the market until the FDA determines it is safe”).
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the Senate “that would require FDA approval for all GE food with
safety data made public and open to comment.”196 The bill was
referred to the Senate committee on October 10, 2002, and then to
the Committee on Agriculture, Nutrition, and Forestry.197 No
subsequent major action has been taken with regard to the bill.198
The continual disregard for consumer concerns will eventually
backfire. Two California counties have recently banned GM crops
because of the agricultural industry’s failure to address the public’s
fears.199 Because of the undisputed benefits of GM foods, banning
such crops is not a good strategy. However, it was a natural
reaction to the “information vacuum” created by the industry’s
refusal to educate the public and address consumer fears.200 The
industry refuses to budge on the labeling issue, but “[i]f biotech and
agriculture companies want people to make sensible choices, they’ll
have to trust them with more information.”201
The U.S. position has been to deny people their right to know
how something is produced and to instead align with biotech
companies that cumulatively spend approximately fifty million
dollars per year propagating biotech foods.202 The ways in which
the U.S. agencies handle GM food regulation send a message that
citizen demands should be ignored.203 Many European countries
also feel that the United States puts too much pressure on and
interferes with the decision-making process in other countries.204
The U.S. regulators, on the other hand, are frustrated with the
196
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Shah, supra note 130; Fisher, supra note 194, at 89 (discussing how newly
developed biotech foods rapidly moved into the marketplace in the United States and
abroad due to the efforts of a small number of United States biotech companies,
marketing GE foods as a solution to world hunger and environmental problems).
203
Shah, supra note 130. See Rich, supra note 28, at 906 (arguing that it is
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Europeans’ resistance to GM foods and claim that their objections
are unreasonable and purely emotional.205
B. Informed Consumer Choice Issues on the International Scene
The regulatory philosophy of the E.U. includes much more of
the conflicting viewpoints of consumers, scientists, and
manufacturers, and reflects a more democratic approach to
labeling.206 Although different legislative institutions have a range
of dissimilar theories on what criteria they should use for labeling,
there is a consensus among lawmakers that it is necessary to label
biotechnology products.207
Of particular curiosity is that while the U.S. regulatory agencies
oppose labeling of GM foods because it can be misleading and
confusing to consumers,208 the E.U. requires labeling in order to
prevent consumers from being misled.209 The Economic and Social
Research Council (ESRC) strongly believes that “[t]o assume that
the public is ignorant is not only patronizing, but inaccurate and
damaging. Global Environmental Change Programme research
reveals that people’s understandings of the issues are very much
better developed than these characterizations imply.”210
V. CONCLUSION
Many scientists agree that although GM food is basically safe,
there could be potential long-term effects. Consequently, there is a
need for independent, objective, unbiased research to explore
possible undesirable effects of biotechnology. The rapid advances
in biotechnology and the increased presence of GM foods in
markets and grocery stores worldwide further aggravate the need
for such research.
205
Kathleen Hart, a journalist writing about health and biotechnology, called the
USDA in order to clarify why the Europeans are so apprehensive about biotechnology.
An assistant to then Agriculture Secretary Dan Glickman assured Ms. Hart that GM
foods do not differ nutritionally from conventional foods and that “[t]he Europeans
were basing their objections not on science…but on emotion.” Hart, supra note 5, ¶ 6.
206
Degnan, supra note 88, at 56.
207
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208
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209
Compton, supra note 10, at 383.
210
ESRC GLOBAL ENVTL. CHANGE PROGRAMME, THE POLITICS OF GM FOOD:
RISK, SCIENCE AND PUBLIC TRUST, special briefing No. 5 (1999), http://www.sussex.
ac.uk/Units/gec/gecko/gec-gm-f.pdf.
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Like any scientific development, biotechnology can be used for
various purposes. It can be “democratically managed to the benefit
of the most needy or skewed to the advantage of specific groups
that hold the vital political, economical and technological
power.”211 After analyzing the progress of bioengineering nearly
two decades ago, Senator Al Gore warned that “[f]or every use of
biotechnology there is potential misuse. For every benefit, there is a
potential hazard. Our challenge is to know when we are about to go
too far.”212 Therefore, in order to maximize the possibilities and
prevent the hazards, governments and people must use this power
rationally.213
The current U.S. system is fragmented and insufficient to
protect consumers because it excludes the public from the decisionmaking process. One commentator criticized the current system’s
inability to effectively address the environmental impact of
biotechnology:
At present, the environmental risks posed by
genetically engineered organisms are not addressed
in a coherent manner. There is no single federal
statute that governs the subject matter. The
regulatory regime that does exist only confronts a
few aspects of the issue, and then only in a
piecemeal, haphazard fashion…. Consequently,
there are sizable gaps in coverage, with the
concomitant risk of significant harms slipping
through the cracks and into the environment.
Additionally, proponents of new and potentially
important genetically engineered “products” are
forced to navigate a confusing maze of agencies and
statutes, with resulting inefficiency and needlessly
steep economic and opportunity costs and delays for
industry and the general public.214
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The United States needs a more centralized regulatory system.
Since increasing and ensuring cooperation between the USDA,
EPA, and FDA will be very difficult, a better approach would be to
create a separate federal agency responsible solely for the research
and regulation of genetically modified organisms. Instead of
relying on the existing regulatory framework, new laws should be
created that would correspond with the demands of biotechnology.
The creation of a new regime will help improve existing protections
for the health of the consumers and the health of the planet.
Furthermore, the United States should adopt labeling standards
to allow consumers to make an informed decision as well as to
instruct, warn, and educate them about choosing their food wisely.
Consumers should have a forum to address their concerns and those
concerns should be listened to—“[t]his is the essence of a
representative government, a fact not lost to the biotech industry,
which has taken full advantage of their lobbying power to ensure
technology-friendly regulations.”215
As for the European policy, as it becomes more liberal in the
interest of improving trade relationships, it needs to remain aware
of other important considerations. The recent changes towards trade
liberalization in Europe are positive for both the E.U. and the
United States. Banning biotechnology, which has so much
potential, is not a good policy, and Europe should be praised for
finally giving genetic engineering a chance to prove its utility.
However, the focus should remain on rational management.
Eventually, the governments and people will be able to achieve a
happy medium because while the United States is tightening its
proposed herein. The statute shall “make sense on a scientific level,” taking into
consideration both the risks and benefits of biotechnology. Moreover, the statute,
“should be an effective mechanism for educating the general public and creating a
productive dialogue with people in the communities most directly affected.” Id. at
863–70.
215
Rich, supra note 28, at 906. See Emily Robertson, Note, Finding a
Compromise in the Debate over Genetically Modified Food: An Introduction to a
Model State Consumer Right-to-Know Act, 9 B.U. J. SCI. & TECH. L. 156, 158 (2003)
(advocating mandatory disclosure of GMOs in food products because consumers
should be able to make informed decisions and “meaningfully participate in [the]
marketplace”); see also Rebecca M. Bratspies, Consuming (F)ears of Corn: Public
Health and Biopharming, 30 AM. J.L. & MED. 371, 403 (2004) (stating that decisions
regarding the regulation of GM foods “should be the product of a public discussion
and decision-making process, not the byproduct of private economic ordering”);
Rebecca Bratspies, The Illusion of Care: Regulation, Uncertainty, and Genetically
Modified Food Crops, 10 N.Y.U. ENVTL. L.J. 297, 355 (2002) (stating that because of
the corrosive effects of public distrust of the regulatory system, precautionary controls
need to be developed that would “enjoy the confidence of the public”).
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laws regarding biotechnology, European policy is becoming more
non-interventional.
The opportunities are great as long as the agenda includes
filling the informational void that has been growing since the
introduction of biotechnology to consumers, catching them in the
crossfire between competing claims and interests.
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